Characterization of myeloid leukemia by monoclonal antibodies, with an emphasis on antibodies against myeloperoxidase

C. E. van der Schoot, A. E. von dem Borne, P. A. Tetteroo

Research output: Contribution to journalArticleAcademicpeer-review

32 Citations (Scopus)

Abstract

Since the last workshop on human leukocyte differentiation antigens, there are 14 well defined cluster-designated (CD) antigens which characterize myelomonocytic cells. Of these, 5 are potentially useful for myeloid leukemia typing (i.e. CD13, CD14, CD15, CD33, CD36) because they are cell lineage-specific and also expressed on immature cells. However, the reactivity of monoclonal anti-CD antibodies, directed against these antigens, with myeloblastic leukemia cells was found to be quite low. We produced monoclonal antibodies against myeloperoxidase. These antibodies react also with promyeloperoxidase, synthesized in HL-60 cell line cells. Monoclonal antimyeloperoxidase was found to be the most sensitive reagent to diagnose acute myeloid leukemia, even more sensitive than cytochemical stains (Sudan black, myeloperoxidase)
Original languageEnglish
Pages (from-to)32-40
JournalActa haematologica
Volume78
Issue numberSuppl. 1
Publication statusPublished - 1987

Cite this